Cognex (CGNX) Cash & Equivalents (2009 - 2026)

Cognex (CGNX) has 18 years of Cash & Equivalents data on file, last reported at $237.3 million in Q2 2026.

• Quarterly Cash & Equivalents rose 65.12% year-over-year to $237.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $237.3 million (up 65.12% YoY) and the FY2025 annual result came in at $262.9 million, up 41.29% from the prior year.
• Cash & Equivalents slipped to $237.3 million in Q2 2026, from $262.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $395.5 million in Q4 2023 to a low of $524000.0 in Q3 2022.
• A 5-year average of $195.4 million and a median of $181.4 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 99.76% — and 2023, when it soared 33771.18%.
• Tracing CGNX's Cash & Equivalents over 5 years: stood at $181.4 million in 2022, then increased by 11.73% to $202.7 million in 2023, then decreased by 8.17% to $186.1 million in 2024, then surged by 41.29% to $262.9 million in 2025, then declined by 9.73% to $237.3 million in 2026.
• The last three Cash & Equivalents figures came in at $237.3 million (Q2 2026), $262.9 million (Q4 2025), and $245.9 million (Q3 2025), per Business Quant data.